Advanced search
Publication Cover
Vascular Health and Risk Management Volume 17, 2021 - Issue
Submit an article Journal homepage
188
Views
0
CrossRef citations to date
0
Altmetric
Review

Ticagrelor Use in Stroke Patients: Past, Present, and Future

Rahul ChandraDepartment of Neurology, Allegheny Health Network, Pittsburgh, PA, USAView further author information
,
Harneel SainiDepartment of Neurology, Allegheny Health Network, Pittsburgh, PA, USAView further author information
,
Russell CerejoDepartment of Neurology, Allegheny Health Network, Pittsburgh, PA, USAView further author information
,
Ashis TayalDepartment of Neurology, Allegheny Health Network, Pittsburgh, PA, USAView further author information
&
Konark MalhotraDepartment of Neurology, Allegheny Health Network, Pittsburgh, PA, USACorrespondence[email protected]
View further author information
Pages 357-362 | Published online: 15 Jun 2021

References

  • Malhotra K, Goyal N, Kasunich AS, et al. Ticagrelor for stroke prevention in patients with vascular risk factors: a systematic review and meta-analysis. J Neurol Sci. 2018;390:212–218. doi:10.1016/j.jns.2018.05.001
  • Dobesh PP, Oestreich JH. Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacother J Hum Pharmacol Drug Ther. 2014;34(10):1077–1090. doi:10.1002/phar.1477
  • Nylander S, Femia EA, Scavone M, et al. Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism. J Thromb Haemost. 2013;11(10):1867–1876. doi:10.1111/jth.12360
  • Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–1057. doi:10.1056/NEJMoa0904327
  • Mahaffey KW, Wojdyla DM, Carroll K, et al. Ticagrelor compared with clopidogrel by geographic region in the platelet inhibition and patient outcomes (PLATO) trial. Circulation. 2011;124(5):544–554. doi:10.1161/CIRCULATIONAHA.111.04749
  • Hiatt WR, Fowkes FG, Heizer G, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2017;376(1):32–40. doi:10.1056/NEJMoa1611688
  • Bonaca MP, Goto S, Bhatt DL, et al. Prevention of stroke with Ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). Circulation. 2016;134(12):861–871. doi:10.1161/CIRCULATIONAHA.116.024637
  • Johnston SC, Amarenco P, Albers GW, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375(1):35–43. doi:10.1056/NEJMoa1603060
  • Wong KSL, Amarenco P, Albers GW, et al. Efficacy and safety of Ticagrelor in relation to aspirin use within the week before Randomization in the SOCRATES Trial. Stroke. 2018;49(7):1678–1685. doi:10.1161/STROKEAHA.118.02055
  • Wang Y, Chen W, Lin Y, et al. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled Phase II trial. BMJ. 2019;365:l2211. doi:10.1136/bmj.l2211
  • Johnston SC, Amarenco P, Denison H, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020;383(3):207–217. doi:10.1056/NEJMoa1916870
  • Verdoia M, Kedhi E, Suryapranata H, De Luca G. Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: a comprehensive meta-analysis of 10 randomized trials. Atherosclerosis. 2019;284:136–147. doi:10.1016/j.atherosclerosis.2019.02.011
  • Charpentier T, Ferdynus C, Lair T, et al. Bleeding risk of ticagrelor compared to clopidogrel in intensive care unit patients with acute coronary syndrome: a propensity-score matching analysis. PLoS One. 2020;15(5):e0232768. doi:10.1371/journal.pone.0232768
  • Cowper PA, Pan W, Anstrom KJ, et al. Economic analysis of Ticagrelor therapy from a U.S. perspective. J Am Coll Cardiol. 2015;65(5):465–476. doi:10.1016/j.jacc.2014.11.034
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12). doi:10.1161/STR.0000000000000211
  • Karan V, Vyas D, Bohra V, Huded V. Ticagrelor use in Indian patients undergoing neuroendovascular procedures: a single center experience. Neurointervention. 2019;14(2):125–130. doi:10.5469/neuroint.2019.00087
  • Amarenco P, Denison H, Evans SR, et al.; THALES Steering Committee and Investigators*. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke. 2020;51(12):3504–3513. PMID: 33198608; PMCID: PMC7678660. doi:10.1161/STROKEAHA.120.032239
  • Ticagrelol versus aspirin inischemic stroke. ICHGCP; n.d. Available from: https://ichgcp.net/clinical-trials-registry/NCT03884530. Accessed June 1, 2021.
  • Clopidogrel with aspirin in high-risk patients with acute non-disabling cerebrovascular events II; n.d. Available from: https://clinicaltrials.gov/ct2/show/NCT04078737. Accessed June 1, 2021.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.